Notwithstanding this limit, there was a modest increase in the antiproliferative effects of GDC-0449 when combined with the AMPK inhibitor (Compound C) in some T-ALL cell lines (Supplementary Figure S4A). This evidence concerns the gene PRKAA1 and acute lymphoblastic leukemia.